USPTO serial 79211617
NEPG
Reviewed by CopyMark Law Group
Reg. 5372309Status 709
- Filing date
- Status date
- Registration date
- Jan 9, 2018
- Examiner
- GILLES, DEBORAH LYNN MEINERS
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NEPG?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
NORTHEAST PHARMACEUTICAL GROUP CO., LTD.
CN
Other trademarks owned by NORTHEAST PHARMACEUTICAL GROUP CO., LTD.
NORTHEAST PHARMACEUTICAL GROUP CO., LTD.
CN
Other trademarks owned by NORTHEAST PHARMACEUTICAL GROUP CO., LTD.
NORTHEAST PHARMACEUTICAL GROUP CO., LTD.
CN
Other trademarks owned by NORTHEAST PHARMACEUTICAL GROUP CO., LTD.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Alex Patel
Alex Patel Patel & Almeida, P.C.16830 Ventura Blvd Suite 360Encino, CA 91436UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Vitamin preparations; Medicines for human purpose, namely vitamins, sulfanilamides, hormones, antibiotics, antivirotics for the treatment of stomach and intestinal diseases, respiratory tract infection diseases, angiocardiopathy and nervous diseases; pharmaceutical preparations for the treatment of stomach and intestinal diseases, respiratory tract infection diseases, angiocardiopathy and nervous diseases; Chemico-pharmaceutical preparations for the treatment of stomach and intestinal diseases, respiratory tract infection diseases, angiocardiopathy and nervous diseases; drugs for medical purposes, namely vitamins, sulfanilamides, hormones, antibiotics, antivirotics for the treatment of stomach and intestinal diseases, respiratory tract infection diseases, angiocardiopathy and nervous diseases; Pharmaceutical preparations in the form of tablet for the treatment of stomach and intestinal diseases, respiratory tract infection diseases, angiocardiopathy and nervous diseases; Traditional Chinese medicinal preparations for the treatment of stomach and intestinal diseases, respiratory tract infection diseases, angiocardiopathy and nervous diseases; nutritional supplements; dietetic foods adapted for medical purposes | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by NORTHEAST PHARMACEUTICAL GROUP CO., LTD.
- Other trademarks owned by NORTHEAST PHARMACEUTICAL GROUP CO., LTD.
- Other trademarks owned by NORTHEAST PHARMACEUTICAL GROUP CO., LTD.
- Other trademarks in Class 005
- Similar marks named NEPG
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 12, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 26, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jul 26, 2024 | C71T | CANCELLED SECTION 71 | — |
| Jan 9, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jun 5, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 6, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 19, 2018 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Apr 19, 2018 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Apr 9, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 9, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 24, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 24, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 21, 2017 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 4, 2017 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 4, 2017 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 4, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 14, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 24, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 23, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 23, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 11, 2017 | RFNP | REFUSAL PROCESSED BY IB | — |
| Jul 21, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 21, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 16, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 15, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 14, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 10, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 10, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 6, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |